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case report
The use of fluorescence in situ 
hybridization in the diagnosis of 
hidden mosaicism: apropos of three 
cases of sex chromosome anomalies
O uso da hibridação in situ com fluorescência no 
diagnóstico de mosaicismo oculto: a propósito de três 
casos de anomalias de cromossomos sexuais
Andréa Trevas Maciel-Guerra1,2, Juliana De Paulo1, Ana Paula Santos1, 
Guilherme Guaragna-Filho3, Juliana Gabriel Ribeiro Andrade1,2, Adriana 
Aparecida Siviero-Miachon4, Ângela Maria Spinola-Castro4, Gil Guerra-Júnior2,3 
SUMMARY
FISH has been used as a complement to classical cytogenetics in the detection of mosaicism in 
sex chromosome anomalies. The aim of this study is to describe three cases in which the final 
diagnosis could only be achieved by FISH. Case 1 was an 8-year-old 46,XY girl with normal fe-
male genitalia referred to our service because of short stature. FISH analysis of lymphocytes with 
probes for the X and Y centromeres identified a 45,X/46,X,idic(Y) constitution, and established 
the diagnosis of Turner syndrome. Case 2 was a 21-month-old 46,XY boy with genital ambiguity 
(penile hypospadias, right testis, and left streak gonad). FISH analysis of lymphocytes and buc-
cal smear identified a 45,X/46,XY karyotype, leading to diagnosis of mixed gonadal dysgenesis. 
Case 3 was a 47,XYY 19-year-old boy with delayed neuromotor development, learning disabili-
ties, psychological problems, tall stature, small testes, elevated gonadotropins, and azoosper-
mia. FISH analysis of lymphocytes and buccal smear identified a 47,XYY/48,XXYY constitution. 
Cases 1 and 2 illustrate the phenotypic variability of the 45,X/46,XY mosaicism, and the impor-
tance of detection of the 45,X cell line for proper management and follow-up. In case 3, abnormal 
gonadal function could be explained by the 48,XXYY cell line. The use of FISH in clinical practice 
is particularly relevant when classical cytogenetic analysis yields normal or uncertain results in 
patients with features of sex chromosome aneuploidy. Arq Bras Endocrinol Metab. 2012;56(8):545-51
SUMÁRIO
FISH tem sido usado como um complemento para a citogenética clássica na detecção de mo-
saicismo em anomalias de cromossomos sexuais. O objetivo deste trabalho é descrever três 
casos nos quais o diagnóstico final só foi obtido por meio de FISH. O caso 1 é uma menina de 8 
anos, 46,XY, com genitália feminina normal, encaminhada ao nosso setor devido à baixa esta-
tura. A análise de linfócitos por FISH com sondas centroméricas de X e Y identificou a constitui-
ção 45,X/46,X,idic(Y) e estabeleceu o diagnóstico de síndrome de Turner. O caso 2 é um menino 
de 21 meses, 46,XY, com ambiguidade genital (hipospadia peniana, testículo à direita e gônada 
disgenética à esquerda). FISH de linfócitos e mucosa oral identificou o cariótipo 45,X/46,XY, 
levando ao diagnóstico de disgenesia gonadal mista. O caso 3 é um rapaz de 19 anos, 47,XYY, 
com atraso de desenvolvimento neuromotor, dificuldade de aprendizado, problemas psico-
lógicos, alta estatura, testículos pequenos, gonadotrofinas elevadas e azoospermia. FISH de 
linfócitos e mucosa oral identificou a constituição 47,XYY/48,XXYY. Os casos 1 e 2 ilustram a 
variabilidade fenotípica do mosaico 45,X/46,XY e a importância da detecção da linhagem 45,X 
na avaliação e na condução dos casos. No caso 3, a função gonadal anormal pôde ser explicada 
pela linhagem 48,XXYY. O uso de FISH na prática clínica é particularmente relevante quando 
a análise citogenética clássica traz resultados normais ou incertos em pacientes com quadro 
sugestivo de uma aneuploidia de cromossomos sexuais. Arq Bras Endocrinol Metab. 2012;56(8):545-51
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INTRODUCTION
Sex chromosome anomalies are the most frequent chromosome abnormalities in newborns, with an 
overall incidence of 1:448 (1). They can be either struc-
tural or numerical, and the latter comprise monosomy 
(45,X or Turner syndrome) and polysomies (47,XXY 
or Klinefelter syndrome; 47,XXX; 47,XYY and rare 
cases of 48,XXXX; 48,XXXY; 48,XXYY; 49,XXXXX; 
and 49,XXXXY chromosome constitutions) (2). While 
individuals with a 47,XXX or 47,XYY karyotype may 
have few or no physical or developmental problems, in 
monosomy and other polysomies, the clinical picture 
usually include growth disorders, primary hypogonad-
ism and (or) multiple congenital anomalies; mental 
deficiency and behavioral problems are also frequent 
features in polysomies with more than three sex chro-
mosomes (2-7) (Table 1).
Mosaicism in sex chromosome anomalies can be 
present in a variety of combinations. This is particu-
larly true in TS, in which about 5% of the cases may 
have normal or structurally abnormal Y chromosome 
in the karyotype, e.g., 45,X/46,XY; 45,X/47,XYY; 
and 45,X/46,idic(Y) (8,9). Mosaicism with a 45,X 
cell line and a second cell line containing a normal or 
abnormal Y chromosome leads to a wide spectrum of 
phenotypes, including streak gonads and female geni-
talia, dysgenetic testes and sex ambiguity, and normal 
virilized male with infertility. In addition, these patients 
may have somatic anomalies characteristic of TS (10). 
Other mosaics of sex chromosome anomalies, includ-
ing monosomic, normal and (or) polisomic cell lines, 
may lead to intermediate phenotypes (2). 
Fluorescence in situ hybridization (FISH) is a cyto-
genetic technique used to detect and localize the pres-
ence or absence of specific DNA sequences on chro-
mosomes. It has been incorporated to clinical practice 
as a valuable tool for the identification and definition 
of chromosome abnormalities, and can be applied to 
metaphase chromosomes preparations and (or) inter-
phase cell nuclei (11). 
Within the group of sex chromosome anomalies, 
FISH analysis has been a complement to classical cyto-
genetics for the identification of marker chromosomes 
(12), and for a more specific and sensitive detection 
of mosaicism (13,14). Moreover, the study of mucosa 
cells has also been proposed as a quick and reliable test 
for the diagnosis of hidden mosaicism (15). This is 
particularly relevant when classical cytogenetic analy-
sis brings normal or uncertain results in patients with 
Table 1. Main features of numerical sex chromosome anomalies
Karyotype Incidence Mental retardation
Behavioral 
disorders Stature Gonadal function
Congenital anomalies/
Additional medical problems Ref.
45,X 1:2,130 F - - Short Hypergonadotropic 
hypogonadism
Dysmorphic picture, CV and renal 
anomalies, autoimmune disorders
1,2
47,XXY 1:576 M Greater frequency 
when compared 
with normal men
Greater frequency 
when compared 
with normal men
Tall Hypergonadotropic 
hypogonadism
Minor physical findings, varicose 
veins, DVT, diabetes mellitus, 
autoimmune disorders
1, 2,6
47,XYY 1:851 M Greater frequency 
when compared 
with normal men
Greater frequency 
when compared 
with normal men
Tall Usually normal Minor physical findings 1,2,6
47,XXX 1:897 F Greater frequency 
when compared 
with normal 
women
Greater frequency 
when compared 
with normal 
women
Tall Usually normal
Unknown frequency of 
premature ovarian failure
Minor physical findings,
low frequency of genitourinary 
anomalies and seizures
1,2,6
48,XXXX
49,XXXXX
? + Variable Short Hypergonadotropic 
hypogonadism
Dysmorphic picture, CV anomalies 6,16
48,XXYY 1:18,000-
1:40,000 M
+ + Tall Hypergonadotropic 
hypogonadism
Dysmorphic picture, CV and renal 
anomalies, type II diabetes, seizures, 
DVT
3,6,7
48,XXXY 1:50,000 M + + Tall Hypergonadotropic 
hypogonadism
Dysmorphic picture, CV and renal 
anomalies, type II diabetes, seizures, 
DVT
4,6,7
49,XXXXY 1:85,000-
1:100,000 M
+ + Short Hypergonadotropic 
hypogonadism
Dysmorphic picture, CV and renal 
anomalies, type II diabetes, seizures, 
DVT
4,6,7
+ = present; - = absent; CV = cardiovascular; DVT = deep vein thrombosis; F = females; M = males.
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features of sex chromosome aneuploidy. The aim of 
this study is to describe three cases of sex chromo-
some anomalies in which the final diagnosis could only 
be achieved by FISH with specific probes for X and Y 
chromosomes.
SUBJECTS AND METHODS
Clinical reports
Case 1
This girl was referred to the University Hospital of 
Universidade Federal de São Paulo (Unifesp) at the 
age of 8 years because of short stature. On physical 
examination, height was 2.25 standard deviations be-
low the mean, and there were some Turner syndrome 
stigmata: low posterior hairline, low-set ears, epican-
thic folds, high-arched palate, micrognathia, webbed 
neck, scoliosis, genu varum, and hyperconvex nails. 
External genitalia were typically female. There were 
no cardiovascular or renal anomalies; thyroid function 
and the growth hormone – insulin-like growth fac-
tor axis were both normal. Ultrasound examination 
revealed hypoplastic uterus, and gonads located in the 
pelvic region. 
Her karyotype was 46,XY (50 cells), and sequen-
cing of the SRY gene did not show any mutation. She 
underwent bilateral gonadectomy, and histopathology 
revealed streak gonads. Hormone replacement therapy 
with female hormones began when she was 12 years old.
When the girl was 18 years old, her short stature 
and TS stigmata, together with the absence of SRY 
mutations, which could enable the diagnosis of com-
plete XY gonadal dysgenesis, led to FISH analysis of 
lymphocytes using the alpha-satellite probes for the X 
(DXZ1) and Y (DYZ3) centromeres, which identified 
mosaicism with a 45,X cell line (Figures 1A and 1B, Ta-
ble 2). In addition, there were two red signals from the 
Y centromere probe both in metaphase chromosomes 
and interphase nuclei, indicating an isodicentric Y chro-
mosome. Thus, the karyotype of the girl was defined 
as 45,X/46,X,idic(Y), and the diagnosis of Turner syn-
drome was established.
Case 2
This 21-month-old boy was referred to the University 
Hospital of Universidade Estadual de Campinas (Uni-
camp) because of genital ambiguity. He was born at 
term from healthy and nonconsanguineous parents 
after an uneventful pregnancy, with birth weight of 
2,850 g and length 47 cm. He had normal neuromo-
tor development and history of painful urination. He 
had a normal 6-year-old sister, and family history was 
unremarkable.
On physical examination, weight (10.1 kg) was 
slightly above the 3rd percentile, and height (77 cm) 
below the 3rd percentile. He had low-set and posteriorly 
rotated ears, a 3-cm phallus with chordee, penile hypo-
spadias. The right gonad was palpable in the scrotum, 
and the left one was not.
Laboratory investigation revealed a 46,XY karyo-
type (50 cells) and prepubertal levels of FSH (1.05 
mIU/mL), LH (< 0.1 mIU/L), and testosterone (< 
0.02 ng/mL). After a human chorionic gonadotropin 
(hCG) stimulation test (three intramuscular injections 
of 2000 IU on successive days) testosterone rose to 1.9 
ng/mL, which is consistent with the expected pattern 
for the male sex.
A few months later, he underwent hypospadias re-
pair and surgical exploration. The left gonad was loca-
ted near the internal inguinal ring; biopsies of this go-
nad and its adnexa revealed prepubertal testis, segments 
of epididimus and uterine tube, and fibromuscular tis-
sue compatible with Müllerian remnants. Further biop-
sies of the left gonad showed only fibrous tissue devoid 
of germ cells, while biopsies of the right gonad showed 
prepubertal testis. The left gonad was then removed, 
and histopathology revealed a streak gonad. 
The child was diagnosed as having XY partial go-
nadal dysgenesis and was followed up thereafter in 
the pediatric endocrinology service. Growth deficien-
cy became more pronounced during follow-up, but 
there were no other associated conditions, and ultra-
sound examination did not reveal any renal anoma-
lies. At the age of 10.9 years, height was 127.5cm (z 
= -2.3; mean target height: 175 cm), and weight 29.5 
kg (z = -1.1).
FISH analysis using centromere probes for the X 
and Y chromosomes was done both in lymphocytes 
and buccal smear cells, and identified mosaicism with 
a 45,X cell line (Figure 1C, Table 2). Thus, the pa-
tient’s karyotype was found to be 45,X/46,XY and his 
diagnosis was changed to mixed gonadal dysgenesis 
(MGD). 
Case 3
A 19-year-old boy was referred to the University 
Hospital of Unicamp due to tall stature, small testes, 
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and elevated gonadotropins. He was born at term af-
ter an uneventful pregnancy with a birth weight of 
2,950 g and length of 49 cm. He had delayed neu-
romotor development, learning disabilities, and dif-
ficulties in relationship with his peers. There was also 
a history of right inguinal hernia repair when he was 
11 years old. He was the younger of two sons of a 
consanguineous couple, and there were no similar 
cases in the family. 
On physical examination, height was 194cm (z = 
2.43; mean target height: 176 cm), and weight 76 kg 
(z = 0.47). There was no dysmorphic picture, no gy-
necomastia, and external genitalia were typically male, 
with a 11.5-cm phallus (slightly above -2.0 standard 
deviations), and both testes palpable in the scrotum 
with reduced volume (right: 12 cm3; left: 10 cm3). Pu-
bic hair was on Tanner stage P5.
Laboratory investigation in two different occasions 
(19 and 19.5 years) revealed high levels of FSH (17 
mIU/mL and 16.14 mIU/mL, normal male range, 
NR, 1.5-12.4), normal to elevated LH (8.30 mIU/mL 
and 10.65 mIU/mL, NR 1.7-8.6), and normal testos-
terone (16.93 and 11.00 pg/mL; NR 8.8-27.0). His 
karyotype was 47,XYY (50 cells), and sperm count re-
vealed azoospermia.
As the picture of hypergonadotropic hypogonad-
ism, microrchidia, and infertility is not typical of the 
47,XYY syndrome, FISH analysis using centromere 
probes for the X and Y chromosomes was done both 
in lymphocytes and buccal smear cells, and identified 
mosaicism with a 48,XXYY cell line. Thus, his karyo-
type was found to be 47,XYY/48,XXYY. Low level mo-
saicism with two other cell lines (46,XY and 47,XXY) 
was also suggested by the results found in interphase 
cells from lymphocytes and buccal smear (Figures 1D-
F, Table 2).
Cytogenetic and FISH analyses
Chromosome analyses were performed on peripheral 
blood lymphocytes using standard techniques and G-
banding. FISH studies were performed on blood sam-
ples using the alpha-satellite probes for the X (DXZ1) 
and Y (DYZ3) centromeres from Kreatech Biotechnol-
ogy in case 1, and from Cytocell® in cases 2 and 3, ac-
cording to the manufacturers’ instructions. 
Our protocol on buccal smear samples was based 
on Shouman and cols. (17) and was modified as fol-
lows: before hybridization, slides were pretreated with 
2X SSC for 2 min at 73°C, and with pepsin (Sigma) 
0.005% in 10 mM HCl for 40 min at 37°C (Sigma) 
to remove excess keratin and cytoplasm; washed with 
phosphate-buffered saline (PBS 1X) and PBS 1X sup-
plemented with 37% formaldehyde; and dehydrated 
with 70%, 85% and 100% ethanol for 1 min each. Slides 
were denatured in 70% formamide/2X SSC for 2 min 
at 73°C, and dehydrated in washes of 70%, 85% and 
100% ethanol for 1 minute each. After hybridization, 
slides were washed with 2X SSC for 5 min at 37°C, 
0.4X SSC/0.15% Tween 20 for 2 min at 73°C, and 2X 
SSC at room temperature before counterstaining with 
DAPI (Cytocell®). 
A hundred to 165 metaphase cells, and 200 to 2,000 
interphase cells from peripheral blood lymphocytes and 
(or) buccal smears were analyzed for each patient.
Table 2. Details of FISH results for each case
Parameters One X signal(%)
One X and one Y 
signals
(%)
One X and two Y 
signals
(%)
Two X and one Y 
signals
(%)
Two X and two Y 
signals
(%)
Total cells
Case 1
Blood metaphase 25 (25) 75 (75) 100
Blood interphase 27 (13.5) 173 (86.5) 200
Case 2
Blood metaphase 15 (10.4) 129 (89.6) 144
Blood interphase 159 (15.9) 841 (84.1) 1000
Buccal cells 234 (23.4) 766 (76.6) 1000
Case 3
Blood metaphase 152 (92.1) 13 (7.9) 165
Blood interphase 62 (6.2) 890 (89) 46 (4.6) 998
Buccal cells 20 (4.3) 131 (28.5) 24 (5.2) 285 (62) 460
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DISCUSSION
Chromosomal mosaicism is defined as the presence of 
two or more karyotypically different cell lines in the 
same individual, and is the result of post-zygotic non-
disjunction, anaphase lag, or structural rearrangement. 
If it occurs when the embryo has only a few cells, mo-
saicism is more evenly spread throughout the body and 
may be detectable in most cell lines and resulting tis-
sues; when it occurs in a cell after extensive differentia-
tion, mosaicism may be confined to only one or few 
tissues. 
Cases 1 and 2 illustrate the phenotypic variability of 
the 45,X/46,XY mosaicism, and the differential diag-
nosis that may arise during investigation. The absence 
of a 45,X cell line in the classical karyotype indicated, 
in case 1, the hypothesis of 46,XY complete gonadal 
dysgenesis (XY CGD), characterized by streak gonads 
and female internal and external genitalia and, in case 
2, 46,XY partial gonadal dysgenesis (XY PGD), char-
acterized by the finding of two dysgenetic testes, or a 
dysgenetic testis and a streak gonad and genital ambi-
guity (18). In both disorders, there may be mutations in 
the SRY gene (19,20) (which are more frequent in XY 
CGD) or the NR5A1 gene (21,22), but the origin may 
also be unknown (which is more frequent in XY PGD). 
Also, in both disorders, streak gonads must be removed, 
as well as dysgenetic testes that are not located in the 
scrotal folds, due to the high risk of neoplastic transfor-
mation (gonadoblastomas and dysgerminomas) (23). 
Growth deficiency was the main clinical feature in-
dicating the possibility of hidden mosaicism in both 
cases, together with dysmorphic features suggestive of 
TS in case 1. The use of FISH enabled these hypothe-
ses to be confirmed, also enabling proper management 
and follow-up of the children. In case 1, final diagnosis 
was TS, defined cytogenetically by the presence of an 
X chromosome, and total or partial absence of the sec-
ond sex chromosome; and defined clinically by a female 
phenotype with short stature and primary hypogonad-
ism in most cases, highly variable dysmorphic picture, 
and associated conditions, such as cardiovascular and 
renal anomalies and hypothyroidism (24).
In case 2, the final diagnosis of MGD was based on 
partial testicular dysgenesis and genital ambiguity in-
Figure 1. FISH using DXZ1 and DYZ3 probes for X and Y chromosomes centromeres (green and red signals, respectively). A) Case 1: metaphase cell with 
a 45,X constitution. B) Case 1: metaphase cell with a 46,X,idic(Y) constitution. C) Case 2: interphase cells from buccal smear on the right, showing only 
one X signal corresponding to the 45,X cell line, and others on the left showing one X and one Y signal (46,XY). D) Case 3: metaphase cell with a 48,XXYY 
constitution. E) Case 3: interphase cells from buccal smear showing two X and two Y signals corresponding to the 48,XXYY cell line, and a cell showing 
two X and one Y signals (47,XXY). F) Case 3: interphase cell from buccal smear showing one X and two Y signals corresponding to the 47,XYY cell line. 
Original magnification x 1,000.
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distinguishable from that of XY PGD, but associated 
with a 45,X/46,XY karyotype, and TS features (25). 
Thus, management and follow-up must be identical to 
those of TS; in addition, in both TS and MGD, the 
use of growth hormone may lead to improvement in 
final height (24,25). Regarding sex hormone replace-
ment, female hormones are necessary in most cases 
of TS, and in the cases of MGD reared as females, in 
whom bilateral gonadectomy must be performed. On 
the other hand, in patients with MGD with a male sex 
assignment, maintenance of at least one testis may allow 
spontaneous male puberty, though secondary failure of 
Leydig cells may require therapy with testosterone (25).
The use of FISH in case 1 also enabled the detec-
tion of a structural anomaly of the Y chromosome (di-
centrism), which is frequently observed in 45,X/46,XY 
mosaicism (26), and had not been described in classical 
karyotypying of the girl. This anomaly predisposes to 
the loss of the Y chromosome during mitotic divisions, 
thus generating the 45,X cell line (27).
In case 3, delayed neuromotor development, learn-
ing disabilities and psychological problems, though in-
frequent in 47,XYY syndrome, were compatible with 
this chromosome constitution. However, low testicular 
volume, hypergonadotropic hypogonadism, and azo-
ospermia are not usually found in individuals with this 
karyotype. The detection of the 48,XXYY cell line by 
FISH explained these findings, which are common in 
this polysomy (Table 1). In individuals with chromo-
somal mosaicism the proportion of normal to abnormal 
cell lines usually varies among tissue types (28), and this 
was also observed in case 3.
Few cases of 47,XYY/48,XXYY mosaicism are 
found in literature (29,30); the clinical picture of two 
of them (29) was very similar to the present case: tall 
stature, mental retardation, behavior problems, and 
physical features of Klinefelter syndrome.
The finding of this second cell line in case 3 did 
not modify the management of this patient, who needs 
monitoring of testosterone levels and, if necessary, an-
drogen replacement (7), though there may be concerns 
about worsening of behavior with this therapy (31).
It is worth commenting that the proportion of 45,X 
cell line in metaphases analyzed by FISH in cases 1 and 
2 (25% and 10%, respectively) was greater than expec-
ted when one considers that the analysis of 50 cells in 
the karyotype in both cases enabled the exclusion of 
mosaicism equal to 6% or greater, with 95% confidence 
(32). However, FISH analysis was done many years af-
ter karyotyping in both cases (10 years in case 1, and 
9 years in case 2). As already pointed out, structural 
anomaly of the Y chromosome in case 1 predisposes to 
loss of this chromosome during mitotic divisions (27), 
and this continuous loss may lead to an increasing pro-
portion of the 45,X cell line. Regarding case 2, in vivo 
studies have shown that the percentage of mosaicism in 
TS can change dramatically over time (33,34).
Although FISH has been widely used in research, 
this technique is rarely used in clinical practice to evalu-
ate individuals whose clinical picture is suggestive of 
a sex chromosome anomalies, since most cases may 
be solved by classical karyotyping. However, FISH is 
a useful tool to investigate atypical cases, such as the 
ones described here. The clinician must keep in mind 
that mosaicism is a frequent feature of sex chromosome 
anomalies, particularly TS, and that the use of FISH 
also in interphase cells from buccal smears may extend 
the investigation to a different tissue, replacing skin bi-
opsy and fibroblast culture in a reliable, fast, and non-
invasive manner (35).
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